20060101
A
61 K 39 395 A 20060101
A
61 P 11 00 A 20060101
A
61 P 37 02 A 20060101
C
07 K 16 28 A MY PI2025006719 20251030 US 63/467,169 20230517 SYNDAX PHARMACEUTICALS, INC.
35 Gatehouse Drive, Building D, Floor 3Waltham, Massachusetts, 02451 US
US ORDENTLICH, Peter
1801 Augustine Cut-Off Wilmington, Delaware, 19803 US
RADOJCIC, Vedran
1801 Augustine Cut-Off Wilmington, Delaware, 19803 US
MANIAM A/L MAHALINGAM
C/O IP RIGHTS (M) SDN. BHD., 135-13-4, MENARA PUTERI, JALAN THAMBY ABDULLAH, BRICKFIELDS, 50470 Wilayah Persekutuan MY
METHODS OF TREATING CHRONIC GRAFT-VERSUS-HOST DISEASE-RELATED BRONCHIOLITIS OBLITERANS SYNDROME USING AN ANTI-COLONY STIMULATING FACTOR 1 RECEPTOR ANTIBODY US PCT/US2024/029683 IB WO/2024/238787 20241121 20241117 20251030 20251030

The present disclosure provides methods of treating chronic graft-versus-host disease (cGVHD)-related bronchiolitis obliterans syndrome using an antibody that binds to colony stimulating factor 1 receptor (CSF-1R). Figure 1